| Mepha Pharma AG - Cansartan-Mepha 4, Tabletten | | 60929 | | 01 | | Cansartan-Mepha 4 | | Tabletten | | C09CA06 | | Candesartan | | 30.11.2010 | | |
| | Composition | | candesartanum cilexetilum 4 mg, maydis amylum, lactosum monohydricum 133.8 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.48 mg, magnesii stearas, pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Candesartanum Cilexetil | 4 mg |
| | BAG: Active Agent | Dose |
|---|
| Candesartanum Cilexetilum | 4 mg |
| | | | Inactive agents | Dose |
|---|
| Carmellosum Natricum Conexum | | | Hydroxypropylcellulosum | | | Lactose Monohydrate | 133.8 mg | | Magnesii Stearas | | | Maydis Amylum | | | Pro Compresso | | | Triethylis Citras | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 008 | 7 Tablet(s) | 1.41 | 10.75 | B | SL | No |
|
|
